Atropine Sulfate Injection — FDA Drug Shortage

No longer listed by FDA — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Nov 7, 2025.

Shortage details

Status
No longer listed by FDA
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-4911-34
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)"
Initial Posting
Nov 7, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.